You are here:
  • Home
  • Krypton – Gefitinib 250
portfolio image

Krypton – Gefitinib 250

Krypton-Gefitinib 250 contains the active substance gefitinib which blocks a protein called ‘epidermal growth factor receptor’ (EGFR). This protein is involved in the growth and spread of cancer cells.
Krypton-Gefitinib 250 is used to treat adults with non-small cell lung cancer. This cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

April 22, 2019

Leave a Reply

Your email address will not be published. Required fields are marked *